|
Return to Article:
|
FINANCE
 |
Anne DeGheest founded the investment and executive management firm MedStars (Los Altos Hills, CA) in 1986. Since then, she has specialized in starting and developing new life sciences companies with innovative products and services. DeGheest previously held operating executive positions at Raychem and in the founding teams of Nellcor, OmniCell, and MedPool, the last of which she founded while an entrepreneur-in-residence for Institutional Venture Partners (Menlo Park, CA). She can be reached at anne@medstars.com.
 |
Lars Enstrom is a managing director in the Drawbridge Special Opportunities business of Fortress Investment Group LLC (New York City), which invests in loan originations and corporate securities. He was previously a director in the healthcare investment banking group in the New York office of Houlihan Lokey Howard & Zukin. Before that, he served as an executive director in the healthcare group of CIBC World Markets, the investment banking arm of the Canadian Imperial Bank of Commerce. He can be reached at lenstrom@fortressinv.com.
 |
Allan W. May is a cofounder of Life Science Angels (Menlo Park, CA), the largest angel organization on the West Coast focused solely on early-stage medical device and life sciences start-ups. May was previously chairman and CEO of Vascular Architects (San Jose). May is an investor in more than 30 medical device and biotech companies, and has been a founder, board member, or CEO of a number of early-stage companies in the life sciences arena. He can be reached at allan@maybiomed.com.
 |
Baiju R. Shah is the president of BioEnterprise (Cleveland), a business formation, recruitment, and acceleration initiative designed to grow healthcare companies and commercialize bioscience technologies in the Cleveland area. Since the initiative was founded, in July 2002, BioEnterprise companies have attracted $270 million in new funding. He can be reached at bshah@bioenterprise.com.
 |
Dennis W. Wahr, MD, is a managing director at RiverVest Venture Partners (St. Louis). He has more than 25 years' experience in medical device development, management, and operations, as well as in clinical practice as a board-certified interventional cardiologist. Prior to joining RiverVest, he was the founder, president, and CEO of Velocimed LLC. He can be reached at dwahr@rivervest.com.
 |
Jay Watkins is managing director of De Novo Ventures (Menlo Park, CA), a healthcare investment firm that currently has $350 million under management. Watkins was a cofounder of Origin Medsystems, a venture-funded medical technology start-up that was purchased by Eli Lilly & Co. in 1992. He can be reached at jay@denovovc.com.
